Hydrogel surfaces to promote attachment and spreading of endothelial progenitor cells

Journal of Tissue Engineering and Regenerative Medicine

Volumn 7, Issue 5, 2013, Pages 337-347

  Camci Unal, Gulden ^a,b   Nichol, Jason William ^a,b   Bae, Hojae ^a,b   Tekin, Halil ^a,b,c   Bischoff, Joyce ^a,d   Khademhosseini, Ali ^a,b,e  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c USA   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

^e HARVARD UNIVERSITY   (United States)

Author keywords

Cardiovascular implants; Endothelial progenitor cells; Heparin; Hyaluronic acid

Indexed keywords

ADHESION; CELL ENGINEERING; COMPOSITE COATINGS; CYTOLOGY; ENDOTHELIAL CELLS; HYDROGELS; ORGANIC ACIDS; TISSUE ENGINEERING;

CARDIOVASCULAR IMPLANTS; CARDIOVASCULAR TISSUE ENGINEERING; CD34 ANTIBODY; CELL SPREADING; CELLS ADHESION; ENDOTHELIAL PROGENITOR CELLS; ENDOTHELIALIZATION; FUNCTIONALIZED; HYDROGEL SURFACES; VASCULAR GRAFTS;

HYALURONIC ACID;

CD34 ANTIBODY; HEPARIN; HYALURONIC ACID;

ARTICLE; CARDIOVASCULAR EQUIPMENT; CELL ADHESION; CELL SPREADING; COMPOSITE MATERIAL; CONTROLLED STUDY; COVALENT BOND; CROSS LINKING; ENDOTHELIAL PROGENITOR CELL; HUMAN; HUMAN CELL; HYDROGEL; IMMOBILIZED CELL; IMPLANT; MACROPHAGE; MATERIAL COATING; MONOLAYER CULTURE; PRIORITY JOURNAL; SURFACE PROPERTY; SYNTHESIS; UMBILICAL VEIN ENDOTHELIAL CELL;

EID: 84877156691     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.517     Document Type: Article

References (52)

1. Aoki J, Serruys PW, van Beusekom H et al. 2005; Endothelial progenitor cell capture by stents coated with antibody against CD34 - the HEALING-FIM (healthy endothelial accelerated lining inhibits neointimal growth-first in man) Registry. J Am Coll Cardiol 45(10): 1574-1579.
2. Aubin H, Nichol JW, Hutson CB et al. 2010; Directed 3D cell alignment and elongation in microengineered hydrogels. Biomaterials 31(27): 6941-6951.
3. Barzu T, Molho P, Tobelem G et al. 1984; Binding of heparin and low-molecular weight heparin fragments to human vascular endothelial cells in culture. Nouv Rev Fr Hematol 26(4): 243-247.
4. Barzu T, Vanrijn J, Petitou M et al. 1986; Endothelial binding sites for heparin. Specificity and role in heparin neutralization. Biochem J 238(3): 847-854.
5. Bos GW, Scharenborg NM, Poot AA et al. 1998; Adherence and proliferation of endothelial cells on surface-immobilized albumin-heparin conjugate. Tissue Eng 4(3): 267-279.
6. Burdick JA, Chung C, Jia XQ et al. 2005; Controlled degradation and mechanical behavior of photopolymerized hyaluronic acid networks. Biomacromolecules 6(1): 386-391.
7. Camci-Unal G, Aubin H, Ahari AF et al. 2010; Surface-modified hyaluronic acid hydrogels to capture endothelial progenitor cells. Soft Matter 6(20): 5120-5126.
8. Capila I, Linhardt RJ. 2002; Heparin-Protein Interactions. Angew Chem Int Ed 41: 390-412.
9. Casu B, Naggi A. 2003; Antiangiogenic heparin-derived heparan sulfate mimics. Pure Appl Chem 75(2-3): 157-166.
10. Center for Disease Control and Protection. 2011; Heart disease is the number one cause of death: http://www.cdc.gov/features/heartmonth/ [accessed 28 January 2011].
11. Chan AKC, Paredes N, Thong B et al. 2004; Binding of heparin to plasma proteins and endothelial surfaces is inhibited by covalent linkage to antithrombin. Thromb Haemostasis 91(5): 1009-1018.
12. Chen RS, Chen YJ, Chen MH et al. 2007; Cell-surface interactions of rat tooth germ cells on various biomaterials. J Biomed Mater Res A 83A(1): 241-248.
13. Chen JL, Chen C, Chen ZY et al. 2010; Collagen/heparin coating on titanium surface improves the biocompatibility of titanium applied as a blood-contacting biomaterial. J Biomed Mater Res A 95A(2): 341-349.
14. Chen YM, Shiraishi N, Satokawa H et al. 2005; Cultivation of endothelial cells on adhesive protein-free synthetic polymer gels. Biomaterials 26(22): 4588-4596.
15. Chou AI, Akintoye SO, Nicoll SB. 2009; Photo crosslinked alginate hydrogels support enhanced matrix accumulation by nucleus pulposus cells in vivo. Osteoarthr Cartilage 17(10): 1377-1384.
16. Cosmi B, Fredenburgh JC, Rischke J et al. 1997; Effect of nonspecific binding to plasma proteins on the antithrombin activities of unfractionated heparin, low-molecular-weight heparin, and dermatan sulfate. Circulation 95(1): 118-124.
17. de Mel A, Jell G, Stevens MM et al. 2008; Biofunctionalization of biomaterials for accelerated in situ endothelialization: a review. Biomacromolecules 9(11): 2969-2979.
18. Fujie T, Furutate S, Niwa D et al. 2010; A nano-fibrous assembly of collagen-hyaluronic acid for controlling cell-adhesive properties. Soft Matter 6(19): 4672-4676.
19. Glimelius B, Busch C, Hook M. 1978; Binding of heparin on surface of cultured human endothelial cells. Thromb Res 12(5): 773-782.
20. Hattori S, Andrade JD, Hibbs JB et al. 1985; Fibroblast cell proliferation on charged hydroxyethyl methacrylate copolymers. J Colloid Interf Sci 104(1): 72-78.
21. He HB, Shirota T, Yasui H et al. 2003; Canine endothelial progenitor cell-lined hybrid vascular graft with nonthrombogenic potential. J Thorac Cardiovasc Surg 126(2): 455-464.
22. Hiebert LM, Jaques LB. 1976; Observation of heparin on endothelium after injection. Thromb Res 8(2): 195-204.
23. Hu M, Sabelman EE, Tsai C et al. 2000; Improvement of Schwann cell attachment and proliferation on modified hyaluronic acid strands by polylysine. Tissue Eng 6(6): 585-593.
24. Jaques LB. 1982; Heparin - a unique misunderstood drug. Trends Pharmacol Sci 3(7): 289-291.
25. Jeon O, Bouhadir KH, Mansour JM et al. 2009; Photocrosslinked alginate hydrogels with tunable biodegradation rates and mechanical properties. Biomaterials 30(14): 2724-2734.
26. Ji Y, Ghosh K, Shu XZ et al. 2006; Electrospun three-dimensional hyaluronic acid nanofibrous scaffolds. Biomaterials 27(20): 3782-3792.
27. Kaushal S, Amiel GE, Guleserian KJ et al. 2001; Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo. Nat Med 7(9): 1035-1040.
28. Kennel SJ, Lankford TK, Foote LJ et al. 1993; CD44 expression on murine tissues. J Cell Sci 104: 373-382.
29. Leach JB, Bivens KA, Patrick CW et al. 2003; Photocrosslinked hyaluronic acid hydrogels: natural, biodegradable tissue engineering scaffolds. Biotechnol Bioeng 82(5): 578-589.
30. Lee JH, Lee JW, Khang G et al. 1998; Cell Behavior on Polymer Surfaces with Different Functional Groups. Plenum Press: New York.
31. Lei YG, Gojgini S, Lam J et al. 2011; The spreading, migration and proliferation of mouse mesenchymal stem cells cultured inside hyaluronic acid hydrogels. Biomaterials 32(1): 39-47.
32. Maroudas NG. 1975; Adhesion and spreading of cells on charged surfaces. J Theor Biol 49(2): 417-424.
33. Mason M, Vercruysse KP, Kirker KR et al. 2000; Attachment of hyaluronic acid to polypropylene, polystyrene, and polytetrafluoroethylene. Biomaterials 21(1): 31-36.
34. Melero-Martin JM, Khan ZA, Picard A et al. 2007; In vivo vasculogenic potential of human blood-derived endothelial progenitor cells. Blood 109(11): 4761-4768.
35. - umbilical cord blood. Stem Cells 22(3): 385-395.
36. Nichol JW, Koshy ST, Bae H et al. 2010; Cell-laden microengineered gelatin methacrylate hydrogels. Biomaterials 31(21): 5536-5544.
37. Nilasaroya A, Poole-Warren LA, Whitelock JM et al. 2008; Structural and functional characterisation of poly(vinyl alcohol) and heparin hydrogels. Biomaterials 29(35): 4658-4664.
38. Patton WA, Granzow CA, Getts LA et al. 1995; Identification of a heparin-binding protein using monoclonal antibodies that block heparin binding to porcine aortic endothelial cells. Biochem J 311: 461-469.
39. Peppas NA, Hilt JZ, Khademhosseini A et al. 2006; Hydrogels in biology and medicine: from molecular principles to bionanotechnology. Adv Mater 18(11): 1345-1360.
40. Psuja P, Drouet L, Zawilska K. 1987; Binding of heparin to human endothelial cell monolayer and extracellular matrix in culture. Thromb Res 47(4): 469-478.
41. Rowley JA, Madlambayan G, Mooney DJ. 1999; Alginate hydrogels as synthetic extracellular matrix materials. Biomaterials 20(1): 45-53.
42. Salek-Ardakani S, Arrand JR, Shaw D et al. 2000; Heparin and heparan sulfate bind interleukin-10 and modulate its activity. Blood 96: 1879-1888.
43. Schmidt D, Breymann C, Weber A et al. 2004; Umbilical cord blood derived endothelial progenitor cells for tissue engineering of vascular grafts. Ann Thorac Surg 78(6): 2094-2098.
44. Schopka S, Schmid T, Schmid C et al. 2010; Current strategies in cardiovascular biomaterial functionalization. Materials 3: 638-655.
45. Slaughter BV, Khurshid SS, Fisher OZ et al. 2009; Hydrogels in regenerative medicine. Adv Mater 21(32-33): 3307-3329.
46. Suri S, Schmidt CE. 2009; Photopatterned collagen-hyaluronic acid interpenetrating polymer network hydrogels. Acta Biomater 5(7): 2385-2397.
47. Trindade ES, Oliver C, Jamur MC et al. 2008; The binding of heparin to the extracellular matrix of endothelial cells upregulates the synthesis of an antithrombotic heparan sulfate proteoglycan. J Cell Physiol 217(2): 328-337.
48. Tsou R, Isik FF. 2001; Integrin activation is required for VEGF and FGF receptor protein presence on human microvascular endothelial cells. Mol Cell Biochem 224(1-2): 81-89.
49. Vanwachem PB, Hogt AH, Beugeling T et al. 1987; Adhesion of cultured human endothelial cells onto methacrylate polymers with varying surface wettability and charge. Biomaterials 8(5): 323-328.
50. Yu Y, Flint AF, Mulliken JB et al. 2004; Endothelial progenitor cells in infantile hemangioma. Blood 103(4): 1373-1375.
51. Zhang WQ, Swanson R, Xiong Y et al. 2006; Antiangiogenic antithrombin blocks the heparan sulfate-dependent binding of proangiogenic growth factors to their endothelial cell receptors - evidence for differential binding of antiangiogenic and anticoagulant forms of antithrombin to proangiogenic heparan sulfate domains. J Biol Chem 281(49): 37302-37310.
52. Zieris A, Prokoph S, Levental KR et al. 2010; FGF-2 and VEGF functionalization of starPEG-heparin hydrogels to modulate biomolecular and physical cues of angiogenesis. Biomaterials 31(31): 7985-7994.